BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//132.216.98.100//NONSGML kigkonsult.se iCalcreator 2.20.4//
BEGIN:VEVENT
UID:20251110T195654EST-4759CHBSNC@132.216.98.100
DTSTAMP:20251111T005654Z
DESCRIPTION:Every year\, billions of dollars are invested by funding agenci
 es in basic and translational research\, yet the path from academic discov
 ery to private investment necessary for the creation of new companies is r
 arely straightforward. In this seminar\, you'll get an inside look at how 
 investors work\, what makes a research idea stand out to venture capitalis
 ts\, and how they evaluate translational value of scientific opportunities
 . By the end of the session\, you’ll have a clearer grasp of the framework
  needed to transition an idea or mechanism discovered in the lab to an inv
 estment phase.\n\nThis event is can be attended in-person at D2R Offices (
 1010 Sherbrooke St. West\, Suite 1800\, 18th floor) OR virtually on Zoom.
 \n\nAbout the Speaker\n\nInès Holzbaur\n\nInès Holzbaur is Founder and Man
 aging Partner of AmorChem. She was instrumental in creating the innovative
  investment model of this early-stage life science fund\, as well as in de
 veloping its operations and investment process. Inès is passionate about b
 ringing early-stage life science investments to fruition and was actively 
 involved in transactions with large pharmaceutical companies\, such as Hof
 fman LaRoche and Vertex Pharmaceuticals. As part of her role at AmorChem\,
  she was a founder of NuChem Sciences\, serving as Chair of its Board of D
 irectors from 2011-2019.\n\nHer dedication to life science extends beyond 
 AmorChem: she recently joined the Investment and Commercialization Committ
 ee of the DNA to RNA | D2R initiative at ɬÀï·¬ and serves as V
 ice-Chair of the Board of both the Quebec Biotechnology Innovation Centre 
 and Génome Québec. Furthermore\, she is an active participant in Montreal 
 InVivo committees and is frequently asked to mentor and teach aspiring bio
 tech professionals.\n\nHer early-stage expertise is valued in other techno
 logical areas as well: in cleantech through her role as Chair of the Inves
 tment Committee of Cycle Momentum and in artificial intelligence through h
 er past participation in Creative Destruction Lab. In addition\, her effor
 ts extend beyond Quebec: she had the pleasure of acting as Chair of the Na
 nomedicine Innovation Network and is a member of the College of Reviewers 
 of the Canadian Institutes of Health Research and of ZonMW\, a Dutch grant
 ing agency.\n\nAfter joining the venture capital industry in the late 1990
 s as an intern for the GeneChem family of funds\, she quickly rose to Part
 ner and invested in Canada\, the UK and the US. The solid reputation she b
 uilt as an investor was recognized through her election to the Board of Ré
 seau-Capital from 2014-2020. Inès holds a PhD in Chemistry from the Univer
 sity of Cambridge\, a Certificate in Leadership from the Institute of Corp
 orate Directors as well as a Certificate in Private Capital Governance fro
 m the Canadian Venture Capital Association.\n\nRegister\n\nBe part of the 
 discussion with AmorChem!\n\nReserve your spot in-person by Nov 24. Space 
 is limited!\n\nRegister here to receive the Zoom link\n\nConfirmation emai
 ls will be provided to registered participants a few days before the event
 .\n
DTSTART:20251128T160000Z
DTEND:20251128T180000Z
SUMMARY:Hybrid Event | D2R Investor Series: Venture Capital Demystified - I
 nvestment Insights with Inès Holzbaur
URL:/medhealthsci/channels/event/hybrid-event-d2r-inve
 stor-series-venture-capital-demystified-investment-insights-ines-holzbaur-
 368827
END:VEVENT
END:VCALENDAR